PharmaMar has requested the process of re-examination for Aplidin® from the EMA
(Pharmamar) PharmaMar (MSE:PHM) has announced the initiation of the re-examination process by the European Medicines Agency (EMA) for Aplidin® (plitidepsin) ...
(Pharmamar) PharmaMar (MSE:PHM) has announced the initiation of the re-examination process by the European Medicines Agency (EMA) for Aplidin® (plitidepsin) ...
Credit: UT Southwestern DALLAS - Jan. 02, 2018 - The most common type of tumor found in the kidney is ...
ARLINGTON, Va. - Jan. 2, 2018 - Scientists and the nation's scientific enterprise remain largely invisible to the public, according ...
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene -- a gene that promotes the ...
ITHACA, N.Y. - An unfortunate church dinner more than 100 years ago did more than just spread typhoid fever to ...
Scientists at Dana-Farber Cancer Institute have shown that experimental diabetes drugs can make cancer cells more vulnerable to traditional chemotherapy ...
PharmaMar (MSE:PHM) has announced today a commercialization and distribution license agreement with Megapharm Ltd. for the marine-derived anticancer drug Aplidin® ...
(New York, NY - January 2, 2018) --Mount Sinai researchers have discovered that normal immune cells called macrophages, which reside ...
1. Risk-based lung cancer screening may save more lives than current USPSTF guidelines Abstract: http://annals.org/aim/article/doi/10.7326/M17-2067 URLs go live when the ...
Credit: University of Colorado Cancer Center Clinical trials of new anti-cancer therapies have often excluded patients whose disease has spread ...
Credit: University of Missouri School of Medicine According to the Centers for Disease Control and Prevention, approximately 12,000 women in ...
Credit: Sarah Pack/Hollings Cancer Center at MUSC As e-cigarettes become more popular, fewer people are taking up smoking traditional cigarettes. ...
Credit: UAB BIRMINGHAM, Ala. - Research led by Ludwine Messiaen, Ph.D., professor of genetics at the University of Alabama at ...
PHILADELPHIA - The proteasome inhibitor carfilzomib has taken on an increasing role in the treatment of multiple myeloma, but new ...
Credit: Hollings Cancer Center Tumor cells use the unfolded protein response to alter circadian rhythm, which contributes to more tumor ...
Credit: Department of Pediatrics, Perinatal and Maternal Medicine (Ibaraki),TMDU Study led by Tokyo Medical and Dental University (TMDU) elucidates genomic ...
Credit: University of Hawaii Cancer Center A University of Hawai'i Cancer Center researcher has identified how some cancer cells are ...
Credit: Credit: Cincinnati Children's CINCINNATI -New research published in the Journal of Experimental Medicine highlights the pernicious effect of obesity ...
Baltimore, Md., Dec. 22, 2017 - The GammaPod ™ - a first-of-its kind stereotactic radiotherapy system to treat early stage ...
Credit: Photo by L. Brian Stauffer CHAMPAIGN, Ill. -- Treating ovariectomized mice with a combination of conjugated estrogens and the ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.